Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma
Author:
Affiliation:
1. Tom Baker Cancer Centre; Medical Oncology; 1331 - 29th Street NW Calgary AB Canada T2N 4N2
2. Program in Evidence-based Care; 1200 Main Street West HSC-2C8 Hamilton ON Canada
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003293/fullpdf
Reference24 articles.
1. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas;Borden;Journal of Clinical Oncology,1987
2. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft tissue sarcomas;Borden;Cancer,1990
3. Combination chemotherapy with adriamycin and streptozotocin. I. Clinical results in patients with advanced sarcoma;Chang;Clinical Pharmacology and Therapeutics,1976
4. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas;Edmonson;Journal of Clinical Oncology,1993
5. Treatment of recurrent or advanced uterine sarcoma: A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group);Muss;Cancer,1985
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Small extracellular vesicles in sarcoma patients follow-up: a pilot study (Preprint);2024-06-27
2. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience;Anticancer Research;2024-06-26
3. Palliative Care Needs of Patients with Musculoskeletal Malignancies;Current Oncology Reports;2024-05-24
4. Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients;Clinical and Translational Oncology;2024-02-03
5. Clinical markers of immunotherapy outcomes in advanced sarcoma;BMC Cancer;2023-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3